U. Costabel (Essen, Germany), M. Drent (Maastricht, The Netherlands)
Alveoscopy in diffuse interstitial lung disease
L. Thiberville, M. Salaun, S. Moreno-Swirc, G. Bourg-Heckly (Rouen, Paris, France)
|  |
Increased pulmonary Wnt signaling in patients with sarcoidosis
B. Levänen, J. Grunewald, A. Eklund, J. Wahlström, M. Nord (Stockholm, Sweden)
|  |
Improvement of the clinical response to infiximab in refractory sarcoidosis by reducing the dose interval
G. Jonker, G. van Kan, E. Ten Hoor-de Groot, M. Drent (Eindhoven, Maastricht, Netherlands)
| |
Restless legs (RLS) and cutaneous temperature thresholds in symptomatic patients with chronic sarcoidosis
J. Verbraecken, M. J. Hermans-Jaspers, C. van der Grinten, P. Bongaerts, N. Cobben, M. Drent (Antwerp (Edegem), Belgium; Maastricht, Netherlands)
| |
The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH)
E. Bargagli, R. Cianti, N. Nikiforakis, B. Magi, M. G. Perari, L. Bini, P. Rottoli (Siena, Italy)
| |
Clinical significance of serum CA 15-3 in patients with idiopathic interstitial pneumonias
A. Ricci, P. Bruno, L. Pisani, L. Tabbì, S. Giovagnoli, S. Mariotta (Rome, Italy)
|  |
Warfarin and survival in people with idiopathic pulmonary fibrosis (IPF)
R. Hubbard, B. Barker, A. Fogarty, C. Smith (Nottingham, United Kingdom)
| |
Effects of proportional assisted ventilation on exercise performance in patients with idiopathic pulmonary fibrosis
E. V. Moderno, W. P. S. Yamaguti, G. Schettino, J. M Salge, R. A. Kairalla, M. A. Martins, C. R. R. Carvalho, C. R. F. Carvalho (São Paulo, SP, Brazil)
| |